Hospital inpatients must have a type and screen performed at least once during the current admission prior to issue of cryoprecipitate. Outpatients must have a type and screen performed during the past 30 days. If type and screen is needed, refer to type and screen test for details concerning specimen requirements.
For FFT: Patients 16 year old and younger: An ABO type (current or historic) is required to provide ABO matched cryoprecipitate. Patients older than 16 yrs: An ABO type (current or historic) is preferred to provide ABO matched product but it is not required. Adult dose is equivalent to two pre pooled cryo
An adequate dose is provided as a pool of individual cryoprecipitates. Additional preparation time is needed for thawing and pooling.
Reference Interval
By report
LOINC Mapping
933-2
LA19725-3
Order Type (Individual or Group)
I
Result Test ID
CRYOP
Reportable?
Y
Result Test Name
CRYOPRECIPITATE
Result Type (Individual or Group)
I
Type (Alpha or Numeric)
N
Default Result
See Unit Status
LOINC Mapping
933-2
LA19725-3
Pricing
Refer to Lab Account Manager. email: labservicesoutreach@urmc.rochester.edu
Specimen Requirements
Patient Preparation
Hospital inpatients must have a type and screen performed at least once during the current admission prior to issue of cryoprecipitate. Outpatients must have a type and screen performed during the past 30 days. If type and screen is needed, refer to type and screen test for details concerning specimen requirements.
For FFT: Patients 16 year old and younger: An ABO type (current or historic) is required to provide ABO matched cryoprecipitate. Patients older than 16 yrs: An ABO type (current or historic) is preferred to provide ABO matched product but it is not required. Adult dose is equivalent to two pre pooled cryo